146 related articles for article (PubMed ID: 4108871)
1. Immunologic enhancement of allogeneic tumor growth with soluble histocompatibility-2 antigens.
Law LW; Appella E; Wright PW; Strober S
Proc Natl Acad Sci U S A; 1971 Dec; 68(12):3078-82. PubMed ID: 4108871
[TBL] [Abstract][Full Text] [Related]
2. Induction of immunological tolerance to soluble histocompatibility-2 antigens of mice.
Law LW; Appella E; Strober S; Wright PW; Fischetti T
Proc Natl Acad Sci U S A; 1972 Jul; 69(7):1858-62. PubMed ID: 4114856
[TBL] [Abstract][Full Text] [Related]
3. Serological and immunogenic activity of soluble mouse transplantation antigens controlled by the H-2 locus.
Strober S; Appella E; Law LW
Proc Natl Acad Sci U S A; 1970 Oct; 67(2):765-72. PubMed ID: 5289019
[TBL] [Abstract][Full Text] [Related]
4. Preparation of dialyzable histocompatibility antigen from BALB-c mice (cell-membrane fragments-proteolytic digestion-detergent solubilization).
Kerman RH; Harris TN; Harris S
Proc Natl Acad Sci U S A; 1972 Jan; 69(1):223-7. PubMed ID: 4500549
[TBL] [Abstract][Full Text] [Related]
5. Distribution of H-2 alloantigenic specificities on radiolabeled papain-solubilized antigen fragments.
Cullen SE; Nathenson SG
J Immunol; 1971 Aug; 107(2):563-70. PubMed ID: 4105541
[No Abstract] [Full Text] [Related]
6. Relationship of tumor-specific transplantation antigens to the histocompatibility complex: dissociation of in vitro alloantigen expression and in vivo alloimmunity from tumor-specific transplantation antigen strength.
Chauvenet PH; Smith RT
Int J Cancer; 1978 Jul; 22(1):79-90. PubMed ID: 79560
[TBL] [Abstract][Full Text] [Related]
7. Biological and biochemical properties of soluble tumor-specific transplantation antigen of a simian virus 40-induced neoplasm.
Appella E; Law LW; Henriksen O
Cancer Res; 1976 Sep; 36(9 PT 2):3539-44. PubMed ID: 184951
[TBL] [Abstract][Full Text] [Related]
8. Distinction between tumor-specific transplantation antigen and virion antigens in solubilized products from membranes of virus-induced leukemic cells.
Chang KS; Law LW; Appella E
Int J Cancer; 1975 Mar; 15(3):483-92. PubMed ID: 49326
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of immunologic enhancement.
Amos DB; Cohen I; Klein WJ
Transplant Proc; 1970 Mar; 2(1):68-75. PubMed ID: 4107294
[No Abstract] [Full Text] [Related]
10. Tumor-associated antigens of rat moloney sarcoma cells. I. Cell-surface antigens.
Leung K; Jones JM; Feldman JD
J Immunol; 1978 Nov; 121(5):1836-43. PubMed ID: 81854
[TBL] [Abstract][Full Text] [Related]
11. Quantitation of partially purified H-2 antigens by micro-complement fixation.
Alspaugh MA; Davis WC
Tissue Antigens; 1972; 2(4):306-15. PubMed ID: 4668411
[No Abstract] [Full Text] [Related]
12. Soluble mouse histocompatibility antigens.
Koene R; McKenzie IF; Painter E; Sachs DH; Winn HJ; Russell PS
Transplant Proc; 1971 Mar; 3(1):231-3. PubMed ID: 4106314
[No Abstract] [Full Text] [Related]
13. Characterization of the immunogenic and serological activity of soluble H-2 transplantation antigens in the mouse.
Strober S; Appella E; Law LW
Transplant Proc; 1971 Mar; 3(1):246-8. PubMed ID: 4106319
[No Abstract] [Full Text] [Related]
14. Immune status of mice tolerant of living cells. II. Continuous presence and nature of facilitation-enhancing antibodies in tolerant animals.
Voisin GA; Kinsky RG; Duc HT
J Exp Med; 1972 May; 135(5):1185-203. PubMed ID: 4623319
[TBL] [Abstract][Full Text] [Related]
15. Effects of placental extracts on the immune response to histocompatibility antigens: class deviation of alloantibody response and allograft enhancement.
Gupta GS; Kinsky RG; Duc HT; Voisin GA
Am J Reprod Immunol (1980); 1984; 6(3):117-23. PubMed ID: 6517178
[TBL] [Abstract][Full Text] [Related]
16. Quantitation of HL-A antigens on cell surfaces.
Lucas ZJ
Transplant Proc; 1971 Mar; 3(1):240-2. PubMed ID: 4106317
[No Abstract] [Full Text] [Related]
17. Immunological enhancement of rat renal allografts using rabbit antisera with specificity for rat transplantation antigens.
Hutchinson IV; Zola H; Batchelor JR
Transplantation; 1976 Sep; 22(3):273-80. PubMed ID: 61635
[TBL] [Abstract][Full Text] [Related]
18. Passive allograft enhancement by subclasses of polyclonal antibodies directed toward restricted regions of the major histocompatibility complex.
Duc HT; Kinsky RG; Voisin GA
Transplantation; 1982 May; 33(5):492-9. PubMed ID: 6806954
[TBL] [Abstract][Full Text] [Related]
19. Common antigenic structures of HL-A antigens. 3. An HL-A common antigenic marker closely associated with HL-A alloantigenic activity and detected by use of rabbit anti-rhesus monkey cell membrane antibodies.
Katagiri M; Tanigaki N; Kreiter VP; Pressman D
Immunology; 1974 Sep; 27(3):487-500. PubMed ID: 4137582
[TBL] [Abstract][Full Text] [Related]
20. Serologically detectable specific and cross-reactive antigens on the membrane of a polyoma virus-induced murine tumor.
Witz IP; Lee N; Klein G
Int J Cancer; 1976 Aug; 18(2):243-9. PubMed ID: 60289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
